SAT0350 Bone mineral density in lupus erythematosus women 1 year after rituximab therapy

Background Patients with systemic lupus erythematosus (SLE) have a higher prevalence of osteoporosis and low bone mineral density (BMD) compared with the general population. Rituximab, a CD20 depleting antibody, has been administrated in patients with refractory SLE. However, to date, its influence...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2013-06, Vol.71 (Suppl 3), p.590-591
Hauptverfasser:	Garcia-Carrasco, M., Mendoza-Pinto, C., Etchegaray-Morales, I., Jimenez-Hernandez, C., Rodriguez-Gallego, A.B., Briones-Rojas, R., Ordoñez-Andrade, E., Mendez-Martinez, S., Aguilar-Cuenca, J.E., Cervera, R.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!